Higher Nicotine Pouch Use Among US Soldiers Revealed

Jan.13.2025
Higher Nicotine Pouch Use Among US Soldiers Revealed
A new study by 29News on Jan 9 shows US soldiers are ten times more likely to use nicotine pouches like ZYN than civilians.

According to a report from 29News on January 9th, a recent study has shown that American soldiers are ten times more likely to use nicotine pouches like ZYN compared to the general population.


A survey conducted at the largest military base in the United States, Fort Bragg, found that 23.8% of service members reported using nicotine pouches at least once in the past 10 days. In contrast, a study of American adults in 2022 found that only 2.9% had used them in the same time period.


The study's co-author, Melissa Little, director of the Nicotine and Tobacco Research Center at the University of Virginia, pointed out that these nicotine pouches are not regulated by the FDA like tobacco products. While some believe that synthetic nicotine may be safer than tobacco, doctors warn that it is too early to draw any conclusions.


Littrell stated that addiction is more common among young and white male soldiers. Despite nicotine and tobacco use historically being a part of military culture, these nicotine pouches are particularly difficult to regulate.


Unlike cigarettes, soldiers can use these nicotine pouches anytime in the field and during training. Littrell says she is not against soldiers choosing to use nicotine pouches, but she hopes they can fully understand the health information and potential risks. She points out that it will take time to determine the specific extent of these risks.


For public health professionals, solving this issue will be particularly challenging, especially among young people and military personnel.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
Philip Morris International (PMI) released its Q4 and full-year 2025 results on February 6, 2026. PMI reported full-year net revenues of $40,648 million ($40.6 billion), reported diluted EPS of $7.26 and adjusted diluted EPS of $7.54. PMI said smoke-free net revenues were $16.9 billion and represented 41.5% of total net revenues, with smoke-free products available in 106 markets and over 43 million estimated adult consumers.
Feb.06 by 2FIRSTS.ai
USITC Issues Final Ruling in 337-TA-1392 Investigation, Imposes Limited Exclusion Order and Cease and Desist Orders
USITC Issues Final Ruling in 337-TA-1392 Investigation, Imposes Limited Exclusion Order and Cease and Desist Orders
USITC issues final ruling on oil vaporizing devices, components violating tariff law, with limited exclusion order and cease-and-desist orders.
Jan.21 by 2FIRSTS.ai
Romania Fines Philip Morris and Distributors Over IQOS Price Fixing
Romania Fines Philip Morris and Distributors Over IQOS Price Fixing
Romania’s Competition Council has found that Philip Morris Trading SRL and two distributors engaged in agreements to fix resale prices and promotional discounts for IQOS heated tobacco products.
Dec.19 by 2FIRSTS.ai
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
Iowa urges Eighth Circuit to allow enforcement of challenged e-cigarette directory law
Iowa urges Eighth Circuit to allow enforcement of challenged e-cigarette directory law
At the U.S. Court of Appeals for the Eighth Circuit, Iowa asked judges to allow enforcement of a challenged 2024 state law that penalizes manufacturers selling e-cigarette products not listed on a state-run directory. Products are listed only when a manufacturer or retailer meets certain premarket requirements established under the federal Food, Drug and Cosmetic Act (FDCA).
Jan.19 by 2FIRSTS.ai
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai